---
schema_version: "secwatch.filing_event.v1"
accession: "0000896622-25-000012"
form_type: "8-K"
ticker: "ATR"
cik: "0000896622"
company_name: "APTARGROUP, INC."
filed_at: "2025-05-01T23:59:59+00:00"
generated_at: "2026-05-23T01:39:50.798196+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# AptarGroup Q1 2025: sales down 3% to $887M, adjusted EPS $1.20, guides Q2 EPS $1.56-$1.64

## Summary
- Reported sales down 3% to $887M; net income down 5% to $79M; adjusted EPS $1.20 vs $1.22 prior year.
- Pharma core sales +3% on drug delivery systems; Beauty core -3% on lower fragrance; Closures core -2%.
- Adjusted EBITDA $183M (+3%); margin 20.7% (+120 bps) driven by pharma royalties.
- Q2 2025 adjusted EPS guidance $1.56-$1.64; effective tax rate 19%-21% vs 24% adjusted prior year.
- Repurchased 548k shares for $80M; quarterly dividend $0.45/share payable May 22, 2025.

## SEC filing metadata
- accession: 0000896622-25-000012
- form_type: 8-K
- ticker: ATR
- cik: 0000896622
- company_name: APTARGROUP, INC.
- filed_at: 2025-05-01T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896622/000089662225000012/0000896622-25-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896622/000089662225000012/atr-20250501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896622-25-000012
- JSON: https://secwatch.observer/filing/0000896622-25-000012.json
- Plain text: https://secwatch.observer/filing/0000896622-25-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.